|
Persistent treatment with cholinesterase inhibitors and/or memantine slows clinical progression of Alzheimer disease
Susan D Rountree, Wenyaw Chan, Valory N Pavlik, Eveleen J Darby, Samina Siddiqui, Rachelle S Doody Alzheimers Res Ther 2009, 1:7 (21 October 2009)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
Editor’s summary
Persistent treatment with cholinesterase inhibitors and/or memantine had a positive impact on Alzheimers disease (AD) progression by multiple cognitive and functional outcome measures.
|